Jobs / United States / Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

Senior Principal Scientist/Principal Scientist, Immune Engagers

Cambridge (USA) Posted today $126,000 - $234,000 per year

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Job Description Summary #LI-Onsite Location: Cambridge, MA, USA At Novartis Oncology Immune Therapeutics we discover and advance immune therapies that harness immune cells against cancer. We are seeking a highly collaborative scientist to lead biology and drug-discovery efforts for novel immune cell engagers and multispecific immune modulators. The successful candidate will combine cancer-immunology expertise, rigorous decision making and cross-functional leadership to advance programs from target validation toward clinical development and contribute to broader immune-engager strategy.   Job Description Key responsibilities • Identify and validate tumor-targeting strategies for immune cell engagers and/or multispecific immune modulators. • Lead biology strategy and execution for multidisciplinary drug-discovery programs, defining goals, critical experiments, decision criteria and differentiated product profiles. • Serve as project team leader and/or biology lead, integrating antibody engineering, disease biology, translational, pharmacology, safety, biomarker, data science and clinical perspectives. • Design and interpret mechanistic studies of immune cell activation, anti-tumor activity, target biology, selectivity, resistance and safety-relevant biology. • Present evidence-based recommendations, risks and development plans at governance reviews. • Supervise and develop scientists while building productive internal and external collaborations. • Contribute to immune-engager strategy, target and indication prioritization, and next-generation modality innovation. Minimum requirements • PhD in cancer biology, immunology or a related discipline with 5+ years of relevant research and/or industry experience; or MS with 10+ years of relevant industry experience. • Strong expertise in cancer biology and/or immunology (especially T cell and/or myeloid cell biology). • Expertise in tumor immunology, especially T cell mediated anti-tumor activity, tumor-associated myeloid cell biology and immune suppression in the tumor microenvironment (TME). • Proficient in immune-cell functional assays and complex immunophenotyping analysis, including integrated in vitro and ex vivo assays as well as multiparameter flow cytometry. • Experience in antibody, multispecific biologic and/or immune-engager discovery within cross-functional teams. • Ability to formulate hypotheses, design rigorous experiments, interpret complex data and translate findings into project decisions, evidenced by a strong track record of research publications. • Excellent communication, presentation, analytical and collaboration skills. • Highly desirable, especially for Senior Principal Scienti st • Strong track record in T-cell engager or myeloid cell-engager discovery, with leadership from target validation through IND-enabling or early clinical activities. • Demonstrated success as a project team leader, aligning multidisciplinary stakeholders and driving decisions through scientific and organizational complexity. • End-to-end program perspective connecting indication biology, modality design, translational strategy, differentiation and development path. • Innovation in next-generation immune engagers or multispecific concepts, such as dual-targeting, logic-gated or TME-dependent approaches, and associated discovery workflows. • Experience in mentoring junior project leaders and a broader scientific reputation demonstrated through publications, patents, presentations or collaborations. Novartis Compensation and Benefit Summary:  Role Leveling (Dual Posting) This is a dual posting. The final level and title will be determined by the hiring team based on skills, experience, and capabilities. The salary for this position is expected to range between: Princ

Apply on employer site ↗